Probenecid increases renal retention and antitumor activity of DFMO in neuroblastoma.
Chad R SchultzMatthew A SwansonThomas C DowlingAndré S BachmannPublished in: Cancer chemotherapy and pharmacology (2021)
Addition of probenecid as an adjuvant to DFMO therapy may be suitable to decrease overall dose and improve drug efficacy in vivo.